CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
High ImpactOriginal article

STAT+: Novartis’ experimental cardiovascular drug fails a pivotal study

Phase 3negativeNegative
AI Analysis

Summary

Novartis' experimental cardiovascular drug failed in a pivotal Phase 3 study, representing a major setback for the company.

Clinical Trial Data

Phase

3

Primary Endpoint

Not Met

Outcome Details

Pivotal study failed

Importance:8/10
Sentiment:
-0.90
clinical trial failurecardiovascularpivotal study
Related Companies

Read the original article

Published by STAT News on September 4, 2026 9:07 PM

Read Original